Prothena Corp Public (PRTA) EBT Margin Growth (1y) (2013 - 2026)

Prothena Corp Public (PRTA) EBT Margin Growth (1y) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1,526.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1,558.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -683.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 452.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Prothena Corp Public 458.13 Mn 128.67 Mn - 223,425.00

Historic Data

Download Data
DateValue
Mar 31, 2026 223,425.00
Dec 31, 2025 -10.00 Mn
Sep 30, 2025 464,021.00
Jun 30, 2025 -188,091.00
Mar 31, 2025 14.67 Mn
Dec 31, 2024 1.95 Mn
Sep 30, 2024 -619,083.00
Jun 30, 2024 151,468.00
Mar 31, 2024 -14.66 Mn
Dec 31, 2023 -2.24 Mn
Sep 30, 2023 321,380.00
Jun 30, 2023 177,925.00
Mar 31, 2023 99,749.00
Dec 31, 2022 283,059.00
Sep 30, 2022 -327,009.00
Jun 30, 2022 -329,126.00
Mar 31, 2022 1.68 Mn
Dec 31, 2021 561,028.00
Sep 30, 2021 1.97 Mn
Jun 30, 2021 1.37 Mn